These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19101580)

  • 1. The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1.
    Plant KE; Anderson E; Simecek N; Brown R; Forster S; Spinks J; Toms N; Gibson GG; Lyon J; Plant N
    Toxicol Appl Pharmacol; 2009 Feb; 235(1):124-34. PubMed ID: 19101580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers.
    Watson DG; Watterson JM; Lenox RH
    J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells.
    Song N; Boku S; Nakagawa S; Kato A; Toda H; Takamura N; Omiya Y; Kitaichi Y; Inoue T; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):183-9. PubMed ID: 22484386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78.
    Wang JF; Bown C; Young LT
    Mol Pharmacol; 1999 Mar; 55(3):521-7. PubMed ID: 10051536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition.
    Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P
    J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.
    Cui J; Shao L; Young LT; Wang JF
    Neuroscience; 2007 Feb; 144(4):1447-53. PubMed ID: 17184924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency.
    Li R; El-Mallahk RS
    Neurosci Lett; 2000 Nov; 294(3):147-50. PubMed ID: 11072136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
    Kurita M; Nishino S; Ohtomo K; Rai M; Shirakawa H; Mashiko H; Niwa S; Nakahata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):600-4. PubMed ID: 17258372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
    Chuang DM
    Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
    Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
    Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
    Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of protein L-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization.
    Lamarre M; Desrosiers RR
    Neuropharmacology; 2008 Oct; 55(5):669-76. PubMed ID: 18582478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells.
    Asghari V; Wang JF; Reiach JS; Young LT
    Brain Res Mol Brain Res; 1998 Jul; 58(1-2):95-102. PubMed ID: 9685595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines.
    Noël A; Barrier L; Rinaldi F; Hubert C; Fauconneau B; Ingrand S
    J Neurosci Res; 2011 May; 89(5):755-63. PubMed ID: 21360572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells.
    Shao L; Young LT; Wang JF
    Biol Psychiatry; 2005 Dec; 58(11):879-84. PubMed ID: 16005436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities.
    Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM
    J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic lithium treatment up-regulates cell surface Na(V)1.7 sodium channels via inhibition of glycogen synthase kinase-3 in adrenal chromaffin cells: enhancement of Na(+) influx, Ca(2+) influx and catecholamine secretion after lithium withdrawal.
    Yanagita T; Maruta T; Nemoto T; Uezono Y; Matsuo K; Satoh S; Yoshikawa N; Kanai T; Kobayashi H; Wada A
    Neuropharmacology; 2009 Sep; 57(3):311-21. PubMed ID: 19486905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
    Lai JS; Zhao C; Warsh JJ; Li PP
    Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid inhibits neurosphere formation by adult subventricular cells by a lithium-sensitive mechanism.
    Zhou Q; Dalgard CL; Wynder C; Doughty ML
    Neurosci Lett; 2011 Aug; 500(3):202-6. PubMed ID: 21741439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.